Commercialization: Page 76

  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    View on Med Ed: The Devil is in the Details

    The Devil is in the Details The ongoing effort by accreditation and monitoring groups to separate commercial interests from continuing medical education (CME) funding appears to be raising as many questions as answers. by Carolyn Gretton It has been a year since Pfizer rocked the CME sector by an...

    By Carolyn Gretton • Aug. 24, 2009
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Jeff George: Stamping a Brand on Generics

    Stamping a BRAND on GENERICS BY KIM RIBBINK Leading a generics company today is a very different undertaking compared with a few years ago. Once considered interlopers in the pharmaceutical industry, generics companies are now big business and are playing a leading role in healthcare decision mak...

    By Kim Ribbink • Aug. 24, 2009
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    What is the Business Case for Tweeting?

    As of August 2009, only 18 pharmaceutical companies were using Twitter, only a few of those were actively Tweeting, and only one encompassed a branded effort. Johnson & Johnson has been the most active, with daily Tweets from Director, Media Relations Marc Monseau and Director, Video Communic...

    By Robin Robinson • Aug. 21, 2009
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Talent Pool

    talent pool executive appointments and promotions in the healthcare industry Pharmaceutical POOL Dr. Ann MILLER Steven SEMBLER Eisai Appoints Two Senior VPs Eisai Inc. has expanded its leadership roster with the hiring of two senior VPs. Ann Miller, M.D., joins Eisai as senior VP, primary care an...

    By PharmaVoice Team • Aug. 21, 2009
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    PharmaTrax

    Biopharma Firms Increasingly Seek Marketing Role in Licensing Deals Large pharmaceutical companies’ growing reliance on alliances and in-licensing to gain access to technologies and new molecular entities from biopharmaceutical firms has strengthened the bargaining position for firms offering the...

    By PharmaVoice Team • Aug. 21, 2009
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    E-Media

    New Electronic and Web-based Applications, Sites, and Technologies Featured Briefs: M|C Communications Partners with Accela on Interactive Video Programming KMR Group Adds Site-Level Module to Patient Enrollment System Moonbay Technology Enters Life-Sciences Industry with EDM System ParagonRx Web...

    By PharmaVoice Team • Aug. 21, 2009
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    What's New

    New healthcare-related products, services, and companies FDA Anticounterfeiting Draft Focuses on Chemical Identifiers The FDA has issued a draft guidance on the use of inks, pigments, flavors, and other physical-chemical identifiers (PCIDs) by manufacturers of solid oral dosage forms, which inclu...

    By PharmaVoice Team • Aug. 21, 2009
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    UpFront

    FDA Vision 6-part Plan to Support Public Health Commissioner of Food and Drugs Margaret A. Hamburg, M.D., has outlined her commitment “to prevent harm to the American people" through swift, aggressive, and effective enforcement of FDA laws and regulations. She highlighted six initial steps design...

    By PharmaVoice Team • Aug. 20, 2009
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Moving Beyond The Click

    Based on both public and proprietary research, it is clear that the Internet is proving to be an effective tool for engaging actual and potential prescribers for a given brand or class of drugs in an intellectual dialog that can change prescribing behavior dramatically. FRED FOARD HAS WATCHED THE...

    By PharmaVoice Team • Aug. 12, 2009
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    The Industry's Top Guns Are Revolving

    The year started with surprising news. In January, Gil Bashe joined Catalyst Communications Inc. as president and CEO. Mr. Bashe, 47, had served as CEO of Health!Quest Global Communication Partners, a private equitysponsored communications network, which was funded by GTCR Golder Rauner LLC, sinc...

    By PharmaVoice Team • Aug. 12, 2009
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Pricing — The Cost of Doing Business

    PICK UP A NEWSPAPER , TURN ON THE TELEVISION, OR LOG ONTO THE INTERNET and almost every week, a politician, agency, or consumer group can be found criticizing the pharmaceutical industry’s pricing, promotional, or marketing practices. Central to the controversy, more often than not, is the cost o...

    By PharmaVoice Team • Aug. 12, 2009
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Outsourcing: Division of Labor

    DIVISION OF LABOR There are about 7,500 projects under development by pharmaceutical and biotechnology companies worldwide, and an estimated 80,000 clinical trials are conducted globally every year. Today, 80% of these clinical trials are funded by private industry rather than by government, acco...

    By PharmaVoice Team • Aug. 12, 2009
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Talent Pool

    Pharma POOL Damian BRAGA Wayne PISANO David J. WILLIAMS Aventis Pasteur Selects President and CEO,Promotes Executives in Global Restructuring David J. Williams has been named president and CEO of Aventis Pasteur, the vaccines business of Aventis Pharma AG. Mr. Williams had been co president and c...

    By PharmaVoice Team • Aug. 12, 2009
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    E-Media

    NEW ELECTRONIC AND WEBBASED APPLICATIONS, SITES, AND TECHNOLOGIES Newton Interactive Inc., a provider of digital solutions for the healthcare industry, has won a Standard of Excellence WebAward for its corporate Website, www.new toninteractive.com. “Winners of the 2001 WebAwards represent some of...

    By PharmaVoice Team • Aug. 12, 2009
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    PharmaTrax

    Internet’s IMPACT ON MEDICAL DECISIONS IS GROWING The Internet is having a significant impact on medical decisions, according to a survey of 400 U.S. physicians.The vast majority of doctors use the Inter net as a tool for enriching their medical knowledge, and the medical information these doctor...

    By PharmaVoice Team • Aug. 12, 2009
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    For Art's Sake

    CREATIVE review What’s black and white and read all over? It’s this innovative page stopper. Using monochrome graphics and powerful words this advertisement paints a colorful story to communicate what this product’s benefits really mean to individual patients and the doctors who manage them. Ther...

    By PharmaVoice Team • Aug. 11, 2009
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    PharmaOutlet

    In a nod to the founding fathers, several states have started a revolution against the tyranny of high margin pharmaceuticals with the uninsured elderly playing the role of constituents deprived of their rights. This time the battlefield is the U.S. courts, and lawyers representing both sides are...

    By Don Sharpe • Aug. 11, 2009
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    What's on your mind: Opinions

    The Time Has Come The idea of setting up a separate agency to oversee postmarketing surveillance has been proposed over the past two to three decades — perhaps now its time has come. I would endorse using a new source of user funds to establish a quasiautonomous agency separate from FDA and indus...

    By PharmaVoice Team • Aug. 11, 2009
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Raise Your Voice: Letters

    Wow! Great! Fantastic! Finally! Over the years I have been championing this message. Leave it to PharmaVOICE to give it the prominence it deserves. Great first step. Now let’s talk about how culture, language, geography, family, age, and gender can impact the understanding of healthcare instructi...

    By PharmaVoice Team • Aug. 11, 2009
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Letter from the Editor

    PUBLISHER Lisa Banket EDITOR Taren Grom CREATIVE DIRECTOR Marah Walsh DIRECTOR OF SALES Darlene Kwiatkowski CONTRIBUTING EDITORS Diane Hoffman Virginia Kirk Denise Myshko Kim Ribbink Deborah Ruriani Lynda Sears Copyright 2002 by PharmaLinx LLC, Titusville, NJ Printed in the U.S.A. Volume Two, Num...

    By Taren Grom • Aug. 11, 2009
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Who's on the List by Section

    The Commanders & Chiefs 12 Ahsan Awan Ross Bjella Laurie Cooke, R.Ph. John Farinacci Tuan Ha-Ngoc Fred Hassan Thomas Hughes, Ph.D. Greg Johnson Rick Keefer Kyle Kennedy William Maichle John Maraganore, Ph.D. Francois Nader, M.D. Nader Naeymi-Rad Angus Russell Laurent Schockmel, DVM Jeffrey St...

    By PharmaVoice Team • July 30, 2009
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    The Reading List

    NON-FICTION Memo to the President: How We Can Restore America’s Reputation and Leadership • Madeleine Albright Making it all Work: Winning at the Game of Work and the Business of Life • David Allen Who Goes First?: The Story of Self-Experimentation in Medicine • Lawrence K. Altman It’s Not About ...

    By PharmaVoice Team • July 30, 2009
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Talent Pool

    Pharmaceutical POOL Dr. Peter CARBERRY Dan DUNHAM Dr. Betsy GAROFALO Walt JOHNSTON Astellas Pharma’s U.S. Subsidiaries Name VPs Tokyo-based Astellas Pharma Inc. has announced a number of new executives at its two U.S.-based subsidiaries. Astellas Pharma Global Development (APGD) has hired Peter C...

    By PharmaVoice Team • July 29, 2009
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    E-Media

    New Electronic and Web-based Applications, Sites, and Technologies Featured Briefs: GfK Announces Additions to Marketing Research Portfolio TVG Offers New Forecasting Suite QuestaWeb Offerings Reduce Costs for Importers, Exporters Skila Launches Global Market Access Management Solution StudyManag...

    By PharmaVoice Team • July 29, 2009
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    What's New

    New Healthcare-related Products, Services, and Companies Featured Briefs: GfK Launches Managed Markets Practice CDM Launches Division Focused on Healthcare Branding Brandtectonics Access Establishes U.S. Office inVentiv Health Rebrands Strategy and Analytics Business GSK, Pfizer Combine HIV Asset...

    By PharmaVoice Team • July 29, 2009